Concord Biotech Ltd, Fundamental analysis

Industry Industry name	Pharmaceuticals
Variance Full Year Net Profit Variance	-31
Equity Latest Equity	10.46
Face Value Latest Face Value	1
Reserves Total Reserve	2006.6
Dividend Full Year Dividend %	755
Sales Turnover Full Year Net Sales	1054.89
Net Profit Full Year Net Profit	238.57
Full Year CPS Full Year Cash Per Share	29.9
Earning Per Share Full Year Earning Per Share	22.8
Quarter CPS Latest quarter Cash Per Share	0
Latest Quarter Date Latest Quarter Yrc	Jun 1, 2026
Latest Quarter Sales Latest Quarter Net Sales	257.49
Previous EPS Previous earnings per share	0
Book Value Book value	192.8
Networth Full Year Return on Networth	13.54
Price/Book Value Price to Book value	6.945021
Yearly PE ratio Full Year Price to Earning per share	58.7
Yearly PC ratio Full Year Price to Cash Per Share	44.8
Bse value BSE Value in lakhs	17.14
Nse value NSE Value in lakhs	609.36
High 52 week high	1614
Low 52 week low	987
Price NSE Current market price	1339
CPM Current market price	1339

Market cap BSE / NSE Market Cap	14003.4
Net profit Latest Quarter Net Profit	58.53
Net profit variance Latest Quarter Net Profit variance	33
Result year Trailing latest month	Jun 1, 2026
TTM Sales Trailing Twelve 12 month Net Sales	1085.75
TTM OP Trailing Twelve 12 month Operating Profit	456.29
TTM OPM Trailing Twelve 12 month Operating Profit Margin	42.03
TTM GP Trailing Twelve 12 month Gross Profit	439.04
TTM GPM Trailing Twelve 12 month Gross Profit Margin	39.61
TTM NP Trailing Twelve 12 month Net Profit	327.92
TTM NPV Trailing Twelve 12 month Net Profit Variane	-21.99
TTM EPS Trailing Twelve 12 month EPS	26.55
TTM PE Trailing Twelve 12 month PE	50.42
TTM CPS Trailing Twelve 12 month CPS	0
Month CPS Month Cash Per Share	0
TTM Depreciation Trailing Twelve 12 month Depreciation	53.75
Equity Latest Equity	10.46
LTP Latest Price (BSE/NSE)	1339
Gross block Latest Gross Block	1161.07
Loans Total loans	2.32
Advances Latest Advances for Banks	0
Net profit asset Latest Assets	0
Year OPM Full Year Operating Profit Margin	32.9
Year GPM Full Year Gross Profit Margin	38
Quarter OPM Latest quater Operation Profit Margin	32

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
+ Sales	310	244	430	204	247	278	326	257
YOY Sales Growth %	18%	1%	35%	-5%	-20%	14%	-24%	26%
Gross Sales	310	244	430	204	247	278	326	257
+ Expenses	176	146	241	143	159	183	208	175
Material Cost %	26%	33%	10%	43%	32%	32%	22%	38%
Raw Material Cost	68	61	80	60	57	67	71	70
Change in Inventory	13	21	-38	28	22	21	0	27
Manufacturing Cost %	21%	24%	17%	29%	26%	25%	23%	30%
Employee Cost %	11%	14%	9%	19%	18%	17%	15%	17%
Other Cost %	-2%	-12%	20%	-21%	-12%	-8%	5%	-16%
Raw Materials %	22%	25%	19%	29%	23%	24%	22%	27%
Purchase of Finished Goods %	7%	5%	2%	6%	6%	7%	5%	4%
Stock Adjustments %	-4%	-8%	9%	-14%	-9%	-8%	-0%	-10%
Power & Fuel %	9%	11%	7%	14%	12%	10%	9%	13%
Other Manufacturing Expenses %	12%	13%	10%	15%	15%	15%	14%	16%
Operating Profit	134	98	189	61	88	95	118	82
OPM %	43%	40%	44%	30%	36%	34%	36%	32%
+ Other Income	10	17	9	15	16	10	15	14
Miscellaneous Income	10	17	9	15	16	10	15	14
Interest	0	0	0	0	0	0	0	0
Depreciation	13	13	15	18	18	19	20	18
Profit before tax	130	101	184	59	86	86	114	78
+ Tax %	27%	25%	24%	25%	26%	26%	22%	26%
Current Tax	34	24	42	14	22	22	29	20
Deferred Tax	1	2	1	1	1	1	-3	0
+ Net Profit	96	76	140	44	63	64	88	58
Extraordinary Income / Expense	0	0	0	0	0	-3	0	0
Exceptional Item	0	0	0	0	0	-3	0	0
Minority Interest (After Tax)	0	0	0	0	1	1	0	1
Net Profit After Minority Interest	96	76	140	44	64	64	89	59
EPS in Rs	9.15	7.26	13.42	4.21	6.03	6.08	8.46	5.52

	Mar 2016	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
+ Sales	290	340	436	512	616	713	853	1,017	1,200	1,055
Sales Growth %		17%	28%	18%	20%	16%	20%	19%	18%	-12%
Gross Sales							853	1,017	1,200	1,055
Excise Duty	14	0	0	0	0	0	0	0	0	0
+ Expenses	150	201	258	318	367	491	510	585	695	691
Material Cost %	22%	19%	25%	25%	18%	23%	21%	23%	25%	23%
Raw Material Cost	68	68	109	135	151	188	196	241	320	317
Change in Inventory	-4	-3	-1	-5	-39	-24	-16	-12	-15	-71
Manufacturing Cost %	11%	12%	14%	13%	9%	12%	14%	13%	12%	14%
Employee Cost %	8%	13%	12%	12%	10%	13%	13%	12%	12%	17%
Other Cost %	11%	14%	8%	11%	22%	20%	11%	10%	9%	11%
Raw Materials %	23%	20%	25%	26%	24%	26%	23%	24%	27%	30%
Purchase of Finished Goods %							3%	6%	5%	6%
Stock Adjustments %	1%	1%	0%	1%	6%	3%	2%	1%	1%	7%
Power & Fuel %	9%	10%	8%	7%	6%	10%	11%	10%	9%	11%
Other Manufacturing Expenses %	2%	3%	6%	6%	2%	2%	3%	3%	2%	3%
Selling & Administration %	7%	6%	7%	6%	5%	10%	10%	9%	8%	10%
Miscellaneous Expenses %	1%	6%	0%	3%	4%	4%	2%	1%	1%	2%
Operating Profit	140	138	178	195	249	222	343	432	505	364
OPM %	48%	41%	41%	38%	40%	31%	40%	42%	42%	35%
+ Other Income	5	18	17	32	14	23	37	37	44	55
Miscellaneous Income							41	43	48	56
Interest	0	1	1	1	1	6	5	3	1	1
Depreciation	10	18	19	21	28	50	54	54	54	74
Profit before tax							322	413	495	345
+ Tax %							25%	25%	25%	25%
Current Tax	40	44	56	55	75	59	80	100	119	86
Deferred Tax	2	0	4	-10	2	4	2	5	4	-1
+ Net Profit							240	308	372	259
Profit Growth %								28%	21%	-30%
Extraordinary Income / Expense							0	0	0	-3
Exceptional Item							0	0	0	-3
Minority Interest (After Tax)	0	0	0	0	0	0	0	0	0	2
Net Profit After Minority Interest	0	0	0	169	235	175	240	308	372	261
EPS in Rs				177.82	247.44	183.93	22.95	29.45	35.52	24.78

	Mar 2016	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	9	10	10	10	10	10	10	10	10	10
Reserves	329	585	673	761	990	1,094	1,280	1,516	1,802	2,007
+ Borrowings	36	22	9	52	86	63	32	10	3	2
Secured Borrowings	29	13	0	36	61	61	31	6	0	0
Unsecured Borrowings	7	9	9	17	25	2	0	4	3	2
+ Other Liabilities	74	69	71	118	97	147	192	164	219	212
Current Liabilities	74	71	70	117	93	147	192	165	220	219
Provisions	26	0	0	2	1	2	36	9	16	11
Minority Interest	0	0	0	0	0	0	0	0	0	-2
Other liability items	1	1	1	2	4	2	2	2	3	4
Total Liabilities	449	685	763	941	1,183	1,313	1,514	1,701	2,034	2,232
+ Fixed Assets	110	189	230	240	546	573	593	575	795	789
Gross Block	192	221	281	310	643	720	792	826	1,095	1,161
Accumulated Depreciation	82	32	51	71	97	147	199	250	301	373
CWIP	70	3	19	141	18	74	173	211	51	79
Investments	43	151	229	199	141	74	137	246	335	491
+ Other Assets	225	343	285	361	477	592	611	668	854	873
Inventories	59	71	92	111	154	195	212	208	240	326
Trade receivables	137	220	159	184	178	232	274	350	522	460
Cash Equivalents	1	2	4	3	61	89	43	47	1	14
Loans n Advances	21	18	16	44	74	45	63	50	60	56
Other asset items	6	31	14	20	11	31	18	13	31	17
Total Assets	449	685	763	941	1,183	1,313	1,514	1,701	2,034	2,232

	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
+ Cash from Operating Activity	155	167	207	246	265	245	267
Profit from Operations	226	331	290	369	450	525	381
Working Capital Changes	-22	-89	-22	-52	-81	-171	-14
Profit Before Tax & Extraordinary Items	214	313	238	322	413	495	345
Depreciation	21	28	50	54	54	54	74
Interest (Net)	1	-1	1	-2	-2	-1	-2
Profit / Loss on Sale of Assets	0	0	0	0	0	0	0
Profit / Loss on Sale of Investments	-23	0	-5	-3	-3	-14	-12
Provisions & Write-offs (Net)	1	0	6	-2	1	-1	-1
Profit / Loss in Forex	3	-1	-2	2	2	-1	-11
Receivables	-30	7	-53	-43	-79	-171	70
Inventories	-20	-42	-42	-17	4	-32	-87
Trade Payables	39	-23	37	10	-11	22	-9
Direct Taxes Paid	-49	-75	-61	-70	-103	-109	-100
+ Cash from Investing Activity	-114	-195	-112	-158	-155	-160	-143
Purchase of Fixed Assets	-157	-204	-156	-145	-86	-111	-95
Sale of Fixed Assets	0	0	0	0	0	0	0
Purchase of Investments	-481	-618	-489	-643	-838	-870	-947
Sale of Investments	524	682	561	583	746	801	882
Interest Received	0	0	4	6	3	3	2
Others	0	-55	-33	41	21	17	14
+ Cash from Financing Activity	-43	31	-100	-85	-99	-99	-113
Proceeds from Other Long-Term Borrowings	48	57	0	0	0	0	0
Repayment of Long-Term Borrowings	-9	-19	-25	-25	-25	0	0
Repayment of Short-Term Borrowings	0	0	0	-4	0	-6	0
Repayment of Financial Liabilities	0	-1	-2	-2	-2	-1	0
Dividend Paid	-81	-6	-71	-54	-71	-92	-112
Interest Paid	0	0	-5	-4	-3	-1	0
Others	0	0	2	3	1	0	0
Net Cash Flow	-1	3	-4	3	12	-14	11